Sign inJoin waitlistJoin the waitlist

Samer Al Hadidi

Clinical Director, Amyloidosis Program · University of Texas Southwestern Medical Center

Credentials: · · · · · · · ·

History

Amyloidosis Program · University of Texas Southwestern Medical Center
Present
University of Texas Southwestern Medical Center
Present

Hematology and Medical Oncology
Baylor College of Medicine
2018–2021
University of Michigan School of Public Health
2015–2017
Internal Medicine
Hurley Medical Center
2013–2016
Internal Medicine
Michigan State University
2013–2016
Baylor College of Medicine
2013–2015
University of Michigan
University of Jordan Faculty of Medicine
2007–2011

Research

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis
Blood Advances · 2023 · Last of 9 authors · Corresponding · 131 citations
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Blood Cancer Journal · 2024 · 95 citations
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma
Haematologica · 2024 · 58 citations

Frits van Rhee
49 papers
Carolina Schinke
42 papers
Maurizio Zangari
41 papers
Sharmilan Thanendrarajan
39 papers
Rajshekhar Chakraborty
19 papers
Meera Mohan
16 papers
Ghulam Mohyuddin
15 papers · 14 as a resident
Guido Tricot
14 papers
Daisy Alapat
11 papers
Anita D'Souza
10 papers
Binod Dhakal
10 papers
AG
Aaron Goodman
8 papers